Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19564636 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Conditions: Anemia;   Myelodysplastic Syndromes
Interventions: Biological: Erythropoietin;   Biological: Filgrastim;   Procedure: Transfusion

Indicates status has not been verified in more than two years